These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11141497)

  • 1. Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy.
    Hall GF; Lee VM; Lee G; Yao J
    Am J Pathol; 2001 Jan; 158(1):235-46. PubMed ID: 11141497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibrillary degeneration can be arrested in an in vivo cellular model of human tauopathy by application of a compound which inhibits tau filament formation in vitro.
    Hall GF; Lee S; Yao J
    J Mol Neurosci; 2002 Dec; 19(3):253-60. PubMed ID: 12540050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interneuronal transfer of human tau between Lamprey central neurons in situ.
    Kim W; Lee S; Jung C; Ahmed A; Lee G; Hall GF
    J Alzheimers Dis; 2010; 19(2):647-64. PubMed ID: 20110609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exonic point mutations of human tau enhance its toxicity and cause characteristic changes in neuronal morphology, tau distribution and tau phosphorylation in the lamprey cellular model of tauopathy.
    Lee S; Jung C; Lee G; Hall GF
    J Alzheimers Dis; 2009; 16(1):99-111. PubMed ID: 19158426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ.
    Hall GF; Yao J; Lee G
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4733-8. PubMed ID: 9114060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human tau filaments induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease.
    Hall GF; Chu B; Lee G; Yao J
    J Cell Sci; 2000 Apr; 113 ( Pt 8)():1373-87. PubMed ID: 10725221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.
    Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB
    Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.
    Ishihara T; Zhang B; Higuchi M; Yoshiyama Y; Trojanowski JQ; Lee VM
    Am J Pathol; 2001 Feb; 158(2):555-62. PubMed ID: 11159192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau and axonopathy in neurodegenerative disorders.
    Higuchi M; Lee VM; Trojanowski JQ
    Neuromolecular Med; 2002; 2(2):131-50. PubMed ID: 12428808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
    Andorfer C; Kress Y; Espinoza M; de Silva R; Tucker KL; Barde YA; Duff K; Davies P
    J Neurochem; 2003 Aug; 86(3):582-90. PubMed ID: 12859672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model.
    Marinković P; Blumenstock S; Goltstein PM; Korzhova V; Peters F; Knebl A; Herms J
    Brain; 2019 Apr; 142(4):1051-1062. PubMed ID: 30847469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
    Götz J; Tolnay M; Barmettler R; Chen F; Probst A; Nitsch RM
    Eur J Neurosci; 2001 Jun; 13(11):2131-40. PubMed ID: 11422454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
    Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
    Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
    Mailliot C; Sergeant N; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L
    FEBS Lett; 1998 Aug; 433(3):201-4. PubMed ID: 9744794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
    Brion JP
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly of filamentous tau aggregates in human neuronal cells.
    Ko LW; Rush T; Sahara N; Kersh JS; Easson C; Deture M; Lin WL; Connor YD; Yen SH
    J Alzheimers Dis; 2004 Dec; 6(6):605-22; discussion 673-81. PubMed ID: 15665401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.